Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
The inflammasome in liver disease
Volume 61, Issue 6, Pages (December 2014)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Volume 44, Issue 4, Pages (April 2006)
The management of childhood liver diseases in adulthood
Immigration and viral hepatitis
Determinants of hepatic effector CD8+ T cell dynamics
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 42, Issue 4, Pages (April 2005)
Volume 69, Issue 2, Pages (August 2018)
Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma  André Lechel, Michael P. Manns, K.Lenhard Rudolph 
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Volume 44, Issue 5, Pages (May 2006)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 62, Issue 3, Pages (March 2015)
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 53, Issue 2, Pages (August 2010)
Volume 65, Issue 2, Pages (August 2016)
S. Tamir Rashid, Graeme J.M. Alexander  Journal of Hepatology 
Senescence in chronic liver disease: Is the future in aging?
Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis – Overlapping or separate diseases?  George J.M. Webster, Stephen.
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Liver stem cells—prospects for clinical use
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 56, Issue 6, Pages (June 2012)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Global burden of alcoholic liver diseases
Volume 64, Issue 6, Pages (June 2016)
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
Volume 51, Issue 2, Pages (August 2009)
Volume 62, Issue 3, Pages (March 2015)
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Genetics of hepatocellular carcinoma: The next generation
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Hepatocyte senescence explains conjugated bilirubinaemia in chronic liver failure  Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology  Volume 63, Issue 2, Pages 532-533 (August 2015) DOI: 10.1016/j.jhep.2015.03.031 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Hepatocyte senescence, jaundice and bilirubin transporters. (A) Hepatocyte telomere length was associated inversely with the serum bilirubin level in 70 patients with non-alcohol related fatty liver disease. (B) Immunohistochemical double-staining showed membranous MRP2 staining in p21-negative (blue nuclei; normal) hepatocytes and a lack of MRP2 staining in p21-positive (brown nuclei; senescent) hepatocytes. (C) MRP2 expression was downregulated and MRP3 expression was upregulated in senescent HepG2 cells. (D) Uptake and conjugation of unconjugated bilirubin is unaffected in senescent hepatocytes; however, altered MRP2 and MRP3 expression in senescent hepatocytes leads to transport of conjugated bilirubin back into the sinusoid rather than the biliary canaliculi. Journal of Hepatology 2015 63, 532-533DOI: (10.1016/j.jhep.2015.03.031) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions